Johannes Wesling Klinikum Minden

Hospital


Location: Minden, Germany (DE) DE

ISNI: 0000000405573596

ROR: https://ror.org/05d89kr76

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Arzneimittel bei Kindern sicher einsetzen (2024) Neubert A, Erdlenbruch B Journal article Epidemiology of patch tested patients with permanent tattoos—A comparative analysis of 9693 IVDK patients (2020–2022) (2024) Schubert S, Oppel E, Bauer A, Schröder-Kraft C, Löffler H, Strom K, Worm M, et al. Journal article Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity (2024) Wang Y, Ertl C, Schmitt C, Hammann L, Kramer R, Grabmaier U, Schöberl F, et al. Journal article Associations between tobacco smoking status and patch test results—A cross-sectional pilot study from the Information Network of Departments of Dermatology (IVDK) (2024) Molin S, Brans R, Bauer A, Becker D, Kreft B, Mahler V, Skudlik C, et al. Journal article Checkpoint inhibitor-induced bullous pemphigoid differs from spontaneous bullous pemphigoid (2024) Kramer N, Müller G, Zierold S, Röckel M, Fröhlich W, Schefzyk M, Kumbrink J, et al. Journal article, Letter Pericardial Effusion Predicts Clinical Outcomes in Patients with COVID-19: A Nationwide Multicenter Study (2024) Bucher AM, Henzel K, Meyer HJ, Ehrengut C, Müller L, Schramm D, Akinina A, et al. Journal article S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“ – update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention (2023) Leiter U, Heppt M, Steeb T, Alter M, Amaral T, Bauer A, Bechara FG, et al. Journal article Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial) (2023) Kähler KC, Hüning S, Nashan D, Meiss F, Rafei-Shamsabadi DA, Rissmann H, Colapietro C, et al. Journal article COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma (2023) Berking C, Livingstone E, Debus D, Loquai C, Weichenthal M, Leiter U, Kiecker F, et al. Journal article Natural History and Developmental Trajectories of Individuals With Disease-Causing Variants in STXBP1 (2023) Thalwitzer KM, Driedger JH, Xian J, Saffari A, Zacher P, Bölsterli BK, Ruggiero SM, et al. Journal article
1 2 3 4 5 ... 9